Director of the Center for RNA Therapeutics @methodstHosp.
Leading RNA Therapeutics by Translating RNA from bench to bedside.
#LeadingRNAtherapeutics#cGMP
Big congrats to Dr. Kristopher Brannan & team at Houston Methodist Hospital's Center for RNA Therapeutics! 🎉 Their DARPA submission for high throughput screening of lipid nanoparticles for mRNA delivery & translation is a game-changer! 👏 #Science#Innovation@bRaNnAn_LAB
Excited to be speaking at the Transformative HealthCare Innovations Across the TMC hosted by the School of Engineering Medicine at Texas A&M University!
I cannot wait to see all that ENMED and the TMC have to offer, Sign up today !
In an effort to advance global disease-defense technology, the Coalition for Epidemic Preparedness Innovations (CEPI) and our Center for RNA Therapeutics, led by Dr. @rnacorejpc, are teaming up to develop a new circular RNA vaccine platform. https://t.co/segybPy7SC
Exciting news from @MIT! Their faculty-led 3-year research program, backed by an $82M investment from @US_FDA, is set to revolutionize mRNA manufacturing.
https://t.co/gqTqXpeJZT
Congratulations to @bRaNnAn_LAB and @yeo_lab on this excellent work now online in Molecular Cell! Use HydRA to determine (at domain-level resolution!) if your protein-of-interest binds RNA.
https://t.co/U8MY9uPZmZ
#RNA#research#leadingmedicine
Outstanding paper on the promise of personalized RNA vaccine for pancreatic cancer, showing the benefit of a vaccine-induced immune response in a small cohort of patients. #RNA#CancerResearch
https://t.co/IbczSjOXUA
A full house at the RNA Therapeutics meeting at the University of Massachusetts to hear the keynote lecture of Dr. Katalin Kariko. Dr. Kariko told the story of her discovery that modified nucleosides were necessary for effective translation of mRNA, making mRNA vaccines possible.
🔬 Big shoutout to @HoustonMethodist RNACore for groundbreaking work in RNA manufacturing, with over 300 unique RNA constructs for 100 clients, including novel RNA vaccines, research tools, and RNA drugs. Speeding RNA ideas from concept to the clinic! #mRNA#ResearchAdvancements
Translating basic science into medicine is one of the goals of the Heart Failure Laboratory at Houston Methodist Hospital. From new diagnostics to a vaccine for the treatment of heart failure…..Watch Us Go! @HFdocbhimaraj@KeithYouker@MethodistHosp
Innovations in the field of drugging RNA with small molecules—including discovery platforms, lead compounds and even lead disease indications—are tightly guarded. Companies are making very different bets, and it’s far from clear which ones will win out https://t.co/MuJZba0V7C
In Kyoto, at the Cardiovascular Bioengineering 2023 meeting, Li Lai gets the Early Career Investigator Award for her presentation on the role of O-Glycnacylation on Angiogenic transdifferentiation!
#CardioTwitter#NIHCVBE2023#bioengineering#Symposium
The RNA core was excited to work with Jr. Faculty member Dr. Anahita Mojiri in her exciting cardiovascular research published in the European Heart Journal that uses hTERT mRNA to improve vascular senescence. https://t.co/50wTmutWnf
LIVE IN ONE HOUR, join us for DeBakey CV Live: Innovation on the Loose with John Cooke, MD, and Li Lai, PhD, featuring Pradeep Natarajan, MD, as they discuss “Polygenic Risk Scoring for Coronary Artery Disease."
Watch Live: https://t.co/MwyzlPMmzW